• 1. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes Stilbenes
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes

Comprehensive Overview of 2-Amino-2,3-diphenylpropanoic Acid (CAS No. 56594-95-7): Properties, Applications, and Research Insights

2-Amino-2,3-diphenylpropanoic Acid (CAS No. 56594-95-7) is a chiral non-proteinogenic amino acid derivative with a unique molecular structure featuring two phenyl groups and an amino functional group. This compound has garnered significant attention in pharmaceutical research due to its potential as a building block for peptidomimetics and its role in asymmetric synthesis. The stereochemical complexity of this molecule makes it particularly valuable for designing enzyme inhibitors and bioactive compounds targeting neurological pathways.

Recent studies highlight the growing demand for chiral auxiliaries like 2-Amino-2,3-diphenylpropanoic Acid in drug discovery programs, especially for CNS disorders. Its structural similarity to phenylalanine derivatives allows for innovative applications in medicinal chemistry, where researchers are exploring its use in allosteric modulator development. The compound's CAS registry number 56594-95-7 frequently appears in patent literature related to GPCR-targeted therapies, reflecting its industrial relevance.

From a synthetic perspective, the α,α-diphenyl glycine motif in this molecule enables fascinating structure-activity relationship (SAR) studies. Laboratories worldwide utilize 56594-95-7 to create conformationally constrained peptide analogs, addressing common challenges in oral bioavailability of therapeutic peptides. The compound's crystalline properties and enantiomeric purity specifications (typically >98% ee) make it suitable for X-ray crystallography studies in protein-ligand interactions.

In material science applications, the diphenyl substitution pattern of 2-Amino-2,3-diphenylpropanoic Acid contributes to novel supramolecular architectures. Researchers are investigating its self-assembly properties for developing bioinspired materials, particularly in molecular recognition systems. The compound's thermal stability (decomposition point >200°C) and solubility profile (soluble in polar aprotic solvents) further expand its utility across disciplines.

Analytical characterization of CAS 56594-95-7 typically involves advanced techniques like HPLC-MS for purity assessment and circular dichroism for stereochemical analysis. The pharmaceutical industry values this compound's scalable synthesis routes, with recent improvements in catalytic asymmetric hydrogenation methods reducing production costs. These advancements address frequent search queries about cost-effective chiral synthons in process chemistry forums.

Environmental and green chemistry considerations for 2-Amino-2,3-diphenylpropanoic Acid production have led to innovative biocatalytic approaches using engineered aminotransferases. This aligns with current trends in sustainable pharmaceutical manufacturing, a hot topic in ACS Green Chemistry discussions. The compound's biodegradation profile and ecotoxicological data are becoming increasingly important for regulatory submissions.

Emerging research explores the metabolite potential of 56594-95-7 derivatives in prodrug design, particularly for blood-brain barrier penetration enhancement. Computational chemists frequently model its molecular descriptors (cLogP ~2.1, PSA ~63 ?2) when developing QSAR models for CNS drug candidates. These applications respond to growing interest in AI-driven drug discovery methodologies.

The patent landscape surrounding 2-Amino-2,3-diphenylpropanoic Acid reveals diverse claims ranging from neuroprotective agents to organocatalysts. Its CAS number 56594-95-7 appears in filings related to Alzheimer's disease therapeutics and Parkinson's disease research, addressing trending healthcare concerns. Analytical method development for this compound often focuses on chiral separation techniques to meet stringent ICH guidelines for pharmaceutical impurities.

Academic interest in 56594-95-7 continues to grow, with over 50 citations in Scopus-indexed publications since 2020. Research hotspots include its incorporation into foldamer designs and molecular switches, capitalizing on the steric hindrance provided by its diphenyl groups. These applications answer frequent queries about smart biomaterials in PubMed search trends.

Quality control protocols for 2-Amino-2,3-diphenylpropanoic Acid emphasize spectroscopic fingerprinting (characteristic 1H NMR peaks at δ 7.2-7.4 ppm for aromatic protons) and chiral HPLC retention times. The compound's storage stability under nitrogen atmosphere and hygroscopic nature are critical considerations for GMP manufacturing environments, addressing practical concerns from process chemists in online forums.

• 23239-35-2((S)-2-Amino-2-methyl-3-phenylpropanoic acid)
• 17350-84-4(α-Methyl-D-phenylalanine)
• 5438-07-3(2-Amino-2-phenylbutyric Acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)